• Study on the Safety and Effectiveness of MB-CART2019.1 for Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    Croatia Hungary

  • Study on Bintrafusp Alfa with Chemoradiation for Patients with Esophageal Squamous Cell Carcinoma

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands

  • Study of Felzartamab for Patients with Membranous Nephropathy Resistant to Anti-CD20 Therapy

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    Italy

  • Study to Predict Tofacitinib Effectiveness in Psoriatic Arthritis Patients Using Tofacitinib, Methotrexate, and Folic Acid

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands

  • Study on the Long-Term Safety of ND0612 (Carbidopa, Levodopa) Infusion for Patients with Advanced Parkinson’s Disease

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria France Italy Poland

  • Study of Eftilagimod Alpha and Paclitaxel in Patients with HER2-Negative/Low Metastatic Breast Cancer

    Not recruiting

    4 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Spain

  • Study on the Effects of Pembrolizumab, Atezolizumab, and Nivolumab in Patients with Advanced Non-Small Cell Lung Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France

  • Study on Tezepelumab for Symptom Relief in Patients Aged 12-80 with Eosinophilic Esophagitis

    Not recruiting

    3 1 1
    Investigated Drugs:
    Austria Belgium Czechia Denmark Finland Germany +7

  • Study on Masupirdine for Treating Agitation in Alzheimer’s Dementia Patients

    Not recruiting

    3 1 1
    Investigated Drugs:
    Croatia Poland

  • Study of nirmatrelvir and ritonavir (Paxlovid) for prevention of long COVID-19 in patients with acute COVID-19 infection in Norway

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Norway

powered by